Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia

Emilio Gonzalez, B. G. Guernsey, N. B. Ingrim, Y. Ichikawa, J. C. Daniels

Research output: Contribution to journalArticle

Abstract

Biweekly 200 mg/kg infusions of immune globulin (Gamimune) were given to a 46-year-old woman with severe common variable immunodeficiency, bronchiectasis, and chronic diarrhea with malabsorption. Failure to achieve therapeutically effective serum IgG concentrations in the face of fulminant sepsis was accompanied by a shortened serum IgG half-life of 10.6 days. Currently recommended doses of 200 mg/kg may prove inadequate in very ill patients with sepsis and malabsorption.

Original languageEnglish (US)
Pages (from-to)945-946
Number of pages2
JournalArchives of Internal Medicine
Volume145
Issue number5
DOIs
StatePublished - 1985

Fingerprint

Intravenous Immunoglobulins
Sepsis
Immunoglobulin G
Common Variable Immunodeficiency
Bronchiectasis
Serum
Half-Life
Immunoglobulins
Diarrhea
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia. / Gonzalez, Emilio; Guernsey, B. G.; Ingrim, N. B.; Ichikawa, Y.; Daniels, J. C.

In: Archives of Internal Medicine, Vol. 145, No. 5, 1985, p. 945-946.

Research output: Contribution to journalArticle

@article{24cdecbe8557424ebd325a1c2f042c2c,
title = "Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia",
abstract = "Biweekly 200 mg/kg infusions of immune globulin (Gamimune) were given to a 46-year-old woman with severe common variable immunodeficiency, bronchiectasis, and chronic diarrhea with malabsorption. Failure to achieve therapeutically effective serum IgG concentrations in the face of fulminant sepsis was accompanied by a shortened serum IgG half-life of 10.6 days. Currently recommended doses of 200 mg/kg may prove inadequate in very ill patients with sepsis and malabsorption.",
author = "Emilio Gonzalez and Guernsey, {B. G.} and Ingrim, {N. B.} and Y. Ichikawa and Daniels, {J. C.}",
year = "1985",
doi = "10.1001/archinte.145.5.945",
language = "English (US)",
volume = "145",
pages = "945--946",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia

AU - Gonzalez, Emilio

AU - Guernsey, B. G.

AU - Ingrim, N. B.

AU - Ichikawa, Y.

AU - Daniels, J. C.

PY - 1985

Y1 - 1985

N2 - Biweekly 200 mg/kg infusions of immune globulin (Gamimune) were given to a 46-year-old woman with severe common variable immunodeficiency, bronchiectasis, and chronic diarrhea with malabsorption. Failure to achieve therapeutically effective serum IgG concentrations in the face of fulminant sepsis was accompanied by a shortened serum IgG half-life of 10.6 days. Currently recommended doses of 200 mg/kg may prove inadequate in very ill patients with sepsis and malabsorption.

AB - Biweekly 200 mg/kg infusions of immune globulin (Gamimune) were given to a 46-year-old woman with severe common variable immunodeficiency, bronchiectasis, and chronic diarrhea with malabsorption. Failure to achieve therapeutically effective serum IgG concentrations in the face of fulminant sepsis was accompanied by a shortened serum IgG half-life of 10.6 days. Currently recommended doses of 200 mg/kg may prove inadequate in very ill patients with sepsis and malabsorption.

UR - http://www.scopus.com/inward/record.url?scp=0021848061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021848061&partnerID=8YFLogxK

U2 - 10.1001/archinte.145.5.945

DO - 10.1001/archinte.145.5.945

M3 - Article

C2 - 3922322

VL - 145

SP - 945

EP - 946

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 5

ER -